Options: Hide MedDRA Preferred Terms , display all 21 labels
Information about indications was extracted from the indications and usage sections of the labels.
Indication | Labels | ||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Blood glucose decreased | x | x | x | x | x | x | |||||||||||||||||
Diabetes mellitus | x | x | x | x | |||||||||||||||||||
Diabetic | x | x | x | x | x | x | |||||||||||||||||
Diabetic retinopathy | x | x | |||||||||||||||||||||
Glucose-6-phosphate dehydrogenase deficiency | x | ||||||||||||||||||||||
Hyperglycaemia | x | x | x | x | x | x | |||||||||||||||||
Ketosis | x | ||||||||||||||||||||||
Nephropathy | x | x | |||||||||||||||||||||
Neuropathy | x | x | |||||||||||||||||||||
Obesity | x | x | x | x | x | x | |||||||||||||||||
Type 1 diabetes mellitus | x | x | |||||||||||||||||||||
Type 2 diabetes mellitus | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | |||
Weight decreased | x | x | x | x | x | x | x |
standard – alternative
100% | ||
75% | ||
50% | ||
10% | ||
frequent (1% to 100%) | ||
infrequent (0.1% to 1%) | ||
rare (<0.1%) | ||
postmarketing | ||
0% | ||
no frequency information | ||
not found on label |